Pacs Group (PACS) closed at $48.00 on November 12, 2026, down 4.1% from the previous close, on volume of 591,967 shares (30-day average 842,428).
Data as of November 12, 2026.
12-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 14, 2026 | Ratio Call Spread 1 by 2 | 20-Nov-2645 : 55[2x] C | 1,500 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
Did PACS Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Thu, 12-Nov 12:19 PM ET)
BrightSpring, Centene stand out as healthcare's most persistent Strong Buys
Seeking Alpha News (Thu, 12-Nov 7:38 AM ET)
Fifty-Eight PACS Post-Acute Locations Named Top Nursing Homes for 2027 by U.S. News & World Report
Business Wire (Tue, 10-Nov 2:45 PM ET)
Oppenheimer Reaffirms Their Buy Rating on PACS Group Inc (PACS)
TipRanks (Tue, 10-Nov 7:56 AM ET)
Omega Reports Third Quarter 2026 Results and Recent Developments
Business Wire (Tue, 3-Nov 4:15 PM ET)
PACS Group, Inc. Reports Third Quarter 2026 Results
Business Wire (Tue, 3-Nov 4:15 PM ET)
Business Wire (Thu, 29-Oct 7:15 AM ET)
PACS Group Schedules Third Quarter 2026 Earnings Release and Conference Call
Business Wire (Tue, 27-Oct 4:22 PM ET)
Omega to Transition Operations of 32 Facilities in Florida to PACS Group
Business Wire (Mon, 5-Oct 2:00 AM ET)
Seventeen PACS Post-Acute Locations Named Top Nursing Homes for 2027 by Newsweek Magazine
Business Wire (Wed, 30-Sep 6:08 PM ET)
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
Pacs Group trades on the NYSE stock market under the symbol PACS.
As of November 12, 2026, PACS stock price declined to $48.00 with 591,967 million shares trading.
PACS has a beta of -0.70, meaning it tends to be less sensitive to market movements. PACS has a correlation of 0.01 to the broad based SPY ETF.
PACS has a market cap of $7.60 billion. This is considered a Mid Cap stock.
Last quarter Pacs Group reported $1 billion in Revenue and $.63 earnings per share. This beat revenue expectation by $42 million and exceeded earnings estimates by $.05.
The top ETF exchange traded funds that PACS belongs to (by Net Assets): VTI, IWM, AVUV, VB, DFAS.
PACS has outperformed the market in the last year with a return of +318.8%, while the SPY ETF gained +11.9%. In the last 3 month period, PACS beat the market returning +5.6%, while SPY returned -1.7%. However, in the most recent 2 weeks PACS has underperformed the stock market by returning -3.4%, while SPY returned -1.6%.
PACS support price is $48.57 and resistance is $51.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PACS shares will trade within this expected range on the day.